ARCHIVES

Anidulafungin Safe And Well-Tolerated In Pediatric Patients With Neutropenia

This article is from The Cancer Letter archive.

Vol. 27 No. 11 | November 26, 2004

Download PDF Visit The Full Archive

Related Articles

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

Administration’s FY 1981 Budget Would Leave Gaps, Curtail Many Program, Without New Cuts

March 28, 1980

FDA Puts Clinical Hold On Gene Therapy Trials

January 24, 2003

DCPC Advisers Ok Four New Grant Programs To Foster Prevention

May 22, 1992

Concepts Approved For New Technology In Computers, Recompetition

November 6, 1987

Prevention Trial Could Stand On Its Own

October 28, 1994